IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate June 21, 2022 Read More »
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders June 9, 2022 Read More »
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits April 18, 2022 Read More »
Phase 1 Clinical Trial Data Indicate IGCÃ’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients December 2, 2021 Read More »
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability September 8, 2021 Read More »
IGC Completes the Final Cohort of its Phase 1 Clinical Trial on Alzheimer’s Patients June 24, 2021 Read More »
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC June 22, 2021 Read More »
